Cargando…
Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences
It is thought that gene conversion (GCV) and somatic hypermutation (SHM) of immunoglobulin (Ig) genes occur in two steps: the generation of uracils in DNA by activation-induced cytidine deaminase, followed by their subsequent repair by various DNA repair pathways to generate sequence-diversified pro...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118177/ https://www.ncbi.nlm.nih.gov/pubmed/17178919 http://dx.doi.org/10.1084/jem.20061835 |
_version_ | 1782140966070648832 |
---|---|
author | Yang, Shu Yuan Fugmann, Sebastian D. Schatz, David G. |
author_facet | Yang, Shu Yuan Fugmann, Sebastian D. Schatz, David G. |
author_sort | Yang, Shu Yuan |
collection | PubMed |
description | It is thought that gene conversion (GCV) and somatic hypermutation (SHM) of immunoglobulin (Ig) genes occur in two steps: the generation of uracils in DNA by activation-induced cytidine deaminase, followed by their subsequent repair by various DNA repair pathways to generate sequence-diversified products. It is not known how either of the two steps is targeted specifically to Ig loci. Because of the tight link between transcription and SHM, we have investigated the role of endogenous Ig light chain (IgL) transcriptional control elements in GCV/SHM in the chicken B cell line DT40. Promoter substitution experiments led to identification of a strong RNA polymerase II promoter incapable of supporting efficient GCV/SHM. This surprising finding indicates that high levels of transcription are not sufficient for robust GCV/SHM in Ig loci. Deletion of the IgL enhancer in a context in which high-level transcription was not compromised showed that the enhancer is not necessary for GCV/SHM. Our results indicate that cis-acting elements are important for Ig gene diversification, and we propose that targeting specificity is achieved through the combined action of several Ig locus elements that include the promoter. |
format | Text |
id | pubmed-2118177 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21181772007-12-13 Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences Yang, Shu Yuan Fugmann, Sebastian D. Schatz, David G. J Exp Med Articles It is thought that gene conversion (GCV) and somatic hypermutation (SHM) of immunoglobulin (Ig) genes occur in two steps: the generation of uracils in DNA by activation-induced cytidine deaminase, followed by their subsequent repair by various DNA repair pathways to generate sequence-diversified products. It is not known how either of the two steps is targeted specifically to Ig loci. Because of the tight link between transcription and SHM, we have investigated the role of endogenous Ig light chain (IgL) transcriptional control elements in GCV/SHM in the chicken B cell line DT40. Promoter substitution experiments led to identification of a strong RNA polymerase II promoter incapable of supporting efficient GCV/SHM. This surprising finding indicates that high levels of transcription are not sufficient for robust GCV/SHM in Ig loci. Deletion of the IgL enhancer in a context in which high-level transcription was not compromised showed that the enhancer is not necessary for GCV/SHM. Our results indicate that cis-acting elements are important for Ig gene diversification, and we propose that targeting specificity is achieved through the combined action of several Ig locus elements that include the promoter. The Rockefeller University Press 2006-12-25 /pmc/articles/PMC2118177/ /pubmed/17178919 http://dx.doi.org/10.1084/jem.20061835 Text en Copyright © 2006, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Yang, Shu Yuan Fugmann, Sebastian D. Schatz, David G. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences |
title | Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences |
title_full | Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences |
title_fullStr | Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences |
title_full_unstemmed | Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences |
title_short | Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences |
title_sort | control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118177/ https://www.ncbi.nlm.nih.gov/pubmed/17178919 http://dx.doi.org/10.1084/jem.20061835 |
work_keys_str_mv | AT yangshuyuan controlofgeneconversionandsomatichypermutationbyimmunoglobulinpromoterandenhancersequences AT fugmannsebastiand controlofgeneconversionandsomatichypermutationbyimmunoglobulinpromoterandenhancersequences AT schatzdavidg controlofgeneconversionandsomatichypermutationbyimmunoglobulinpromoterandenhancersequences |